ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

Fairmount Funds Management LLC's Holding History (CIK: 0001802528)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 3,711,444 Value ($000) $57,156 Avg Close $19.92 Range $15.14 - $24.64
Q3 2025
Shares 3,711,444 Value ($000) $75,973 Avg Close $20.16 Range $17.43 - $24.38
Q2 2025
Shares 3,711,444 Value ($000) $74,452 Avg Close $18.93 Range $13.30 - $24.11
Q1 2025
Shares 3,202,798 Value ($000) $63,031 Avg Close $21.52 Range $18.67 - $25.37
Q4 2024
Shares 3,202,798 Value ($000) $72,063 Avg Close $25.92 Range $21.43 - $30.03
Q3 2024
Shares 3,202,798 Value ($000) $81,799 Avg Close $23.16 Range $20.63 - $27.67
Q2 2024
Shares 3,202,798 Value ($000) $74,849 Avg Close $21.05 Range $15.96 - $26.00
Q1 2024
Shares 3,202,798 Value ($000) $56,337 Avg Close $15.34 Range $10.90 - $19.50
Q4 2023
Shares 2,131,369 Value ($000) $29,498 Avg Close $12.23 Range $9.80 - $15.41
Q3 2023
Shares 2,131,369 Value ($000) $29,115 Avg Close $16.84 Range $12.38 - $20.77
Q2 2023
Shares 2,124,625 Value ($000) $43,364 Avg Close $20.21 Range $17.15 - $23.98
Q1 2023
Shares 1,924,938 Value ($000) $42,156 Avg Close $20.34 Range $14.56 - $25.34